The glp·helper blog

How GLP-1 medications work, what the trials show, what they cost, and how to find a provider. All of it is grounded in FDA labels and peer-reviewed research.

Showing: Side effectsAll posts

Side effects

Mounjaro side effects: label rates by dose

12 to 18 percent is Mounjaro's nausea rate by dose, per the FDA label, plus hypoglycemia rates with insulin and sulfonylureas, and the thyroid tumor warning.

Side effects

Zepbound side effects: what the 2026 label says, by dose

25 to 29% of adults on Zepbound had nausea vs 8% on placebo. Zepbound side effects by dose, how long they last, cancer risk, women, and Zepbound vs Wegovy.

Side effects

Wegovy side effects: what the 2026 label says, by dose

44% of adults on Wegovy 2.4 mg had nausea in trials. Every side effect by dose, the 7.2 mg and pill data, how long each one lasts, and the warning signs.

Side effects

Ozempic Side Effects in Men: Testosterone, Muscle, ED

The gut effects match women. Three do not: muscle loss, testosterone, and erections. One ED database signal is 1.47% vs 0.32%. STEP-1 lean mass fell 9.7%.

Side effects

GLP-1 Hair Loss: Why It Happens, Who It Affects, and How to Prevent It

GLP-1 hair loss affects about 2.5% in trials (more with big weight loss) and mostly women. It is telogen effluvium from rapid loss — preventable and reversible.

Side effects

GLP-1 Side Effects: Full Timeline and How Long They Last

GLP-1 side effects like nausea peak in the first weeks of each dose and ease by weeks 6–8. The week-by-week timeline, surgery precautions, and when to call.

Side effects

Ozempic Face: The Real Biological Mechanism Behind Facial Volume Loss

Ozempic face is mostly rapid facial fat loss, about 7% of midface volume per 10 kg in 2025 Vanderbilt imaging. It is not on the label, and collagen damage is unproven. What helps.